Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · see citing works

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · see citing works

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · see citing works

Modulation of oxidative stress as an anticancer strategy

Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · see citing works

The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1

Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · see citing works

From Krebs to clinic: glutamine metabolism to cancer therapy

Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119 · see citing works

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · see citing works

Drugging the undruggable RAS: Mission Possible?

Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997 · see citing works

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990 · see citing works

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Mendoza, M. C., Er, E. E., & Blenis, J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.03.006 · Cited by 1,817 · see citing works

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798 · see citing works

Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791 · see citing works

Glutamine addiction: a new therapeutic target in cancer

Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770 · see citing works

A Restriction Point for Control of Normal Animal Cell Proliferation

Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,416 · see citing works

An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis

Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.07.016 · Cited by 1,388 · see citing works

Reductive carboxylation supports growth in tumour cells with defective mitochondria

Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328 · see citing works

Glutamine and cancer: cell biology, physiology, and clinical opportunities

Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262 · see citing works

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,250 · see citing works

Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells

Sullivan, L. B., Gui, D. Y., Hosios, A. M., Bush, L. N., Freinkman, E., & Vander Heiden, M. G. (2015) · Cell · doi:10.1016/j.cell.2015.07.017 · Cited by 1,173 · see citing works

Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling

Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055 · see citing works

Rheb Binds and Regulates the mTOR Kinase

Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005 · see citing works

Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability

Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975 · see citing works

Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer

Koppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0288-x · Cited by 932 · see citing works

Is Glutamine a Conditionally Essential Amino Acid?

Lacey, J. M., & Wilmore, D. W. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1990.tb02967.x · Cited by 808 · see citing works

Differential regulation of mTORC1 by leucine and glutamine

Jewell, J. L., Kim, Y. C., Russell, R. C., Yu, F.-X., Park, H. W., Plouffe, S. W., Tagliabracci, V. S., & Guan, K.-L. (2015) · Science · doi:10.1126/science.1259472 · Cited by 757 · see citing works

Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer

Davidson, S. M., Papagiannakopoulos, T., Olenchock, B. A., Heyman, J. E., Keibler, M. A., Luengo, A., Bauer, M. R., Jha, A. K., O’Brien, J. P., Pierce, K. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.007 · Cited by 737 · see citing works

Glutaminolysis Activates Rag-mTORC1 Signaling

Durán, R. V., Oppliger, W., Robitaille, A. M., Heiserich, L., Skendaj, R., Gottlieb, E., & Hall, M. N. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.043 · Cited by 723 · see citing works

Signal integration by mTORC1 coordinates nutrient input with biosynthetic output

Dibble, C. C., & Manning, B. D. (2013) · Nature Cell Biology · doi:10.1038/ncb2763 · Cited by 716 · see citing works

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · see citing works

Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine

Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651 · see citing works

The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type

Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.015 · Cited by 639 · see citing works

Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

Timmerman, L. A., Holton, T., Yuneva, M., Louie, R. J., Padró, M., Daemen, A., Hu, M., Chan, D. A., Ethier, S. P., van ‘t Veer, L. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.020 · Cited by 573 · see citing works

Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo

Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.-L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.001 · Cited by 529 · see citing works

Pyruvate carboxylase is critical for non–small-cell lung cancer proliferation

Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497 · see citing works

Amino Acid Transporters in Cancer and Their Relevance to “Glutamine Addiction”: Novel Targets for the Design of a New Class of Anticancer Drugs

Bhutia, Y. D., Babu, E., Ramachandran, S., & Ganapathy, V. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3745 · Cited by 483 · see citing works

Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression

Gille, H., & Downward, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.22033 · Cited by 409 · see citing works

Drugging RAS: know the enemy

Papke, B., & Der, C. J. (2017) · Science · doi:10.1126/science.aam7622 · Cited by 399 · see citing works

Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells.

Zetterberg, A., & Larsson, O. S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5365 · Cited by 372 · see citing works

Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin

Toschi, A., Lee, E., Xu, L., Garcia, A., Gadir, N., & Foster, D. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00782-08 · Cited by 334 · see citing works

Ammonia Derived from Glutaminolysis Is a Diffusible Regulator of Autophagy

Eng, C. H., Yu, K., Lucas, J., White, E., & Abraham, R. T. (2010) · Science Signaling · doi:10.1126/scisignal.2000911 · Cited by 334 · see citing works

The activation of phosphatidylinositol 3-kinase by Ras

Kodaki, T., Woscholski, R., Hallberg, B., Rodriguez-Viciana Julian Downward, P., & Parker, P. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00177-9 · Cited by 329 · see citing works

Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition

Muir, A., Danai, L. V., Gui, D. Y., Waingarten, C. Y., Lewis, C. A., & Vander Heiden, M. G. (2017) · eLife · doi:10.7554/elife.27713 · Cited by 311 · see citing works

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer

Hao, Y., Samuels, Y., Li, Q., Krokowski, D., Guan, B.-J., Wang, C., Jin, Z., Dong, B., Cao, B., Feng, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11971 · Cited by 290 · see citing works

Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia

Kung, H.-N., Marks, J. R., & Chi, J.-T. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002229 · Cited by 277 · see citing works

Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s)

Foster, D. A., Yellen, P., Xu, L., & Saqcena, M. (2010) · Genes & Cancer · doi:10.1177/1947601910392989 · Cited by 272 · see citing works

Involvement of Ral GTPase in v-Src-induced phospholipase D activation

Jiang, H., Luo, J.-Q., Urano, T., Frankel, P., Lu, Z., Foster, D. A., & Feig, L. A. (1995) · Nature · doi:10.1038/378409a0 · Cited by 265 · see citing works

The restriction point and control of cell proliferation

Planas-Silva, M. D., & Weinberg, R. A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80076-2 · Cited by 249 · see citing works

MYC and tumor metabolism: chicken and egg

Dejure, F. R., & Eilers, M. (2017) · The EMBO Journal · doi:10.15252/embj.201796438 · Cited by 240 · see citing works

Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo

Kim, J., Lee, J. H., & Iyer, V. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001798 · Cited by 219 · see citing works

Control of glutamine metabolism by the tumor suppressor Rb

Reynolds, M. R., Lane, A. N., Robertson, B., Kemp, S., Liu, Y., Hill, B. G., Dean, D. C., & Clem, B. F. (2014) · Oncogene · doi:10.1038/onc.2012.635 · Cited by 216 · see citing works

Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth

van den Heuvel, A. P. J., Jing, J., Wooster, R. F., & Bachman, K. E. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21348 · Cited by 209 · see citing works

HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5

Elorza, A., Soro-Arnáiz, I., Meléndez‐Rodríguez, F., Rodríguez-Vaello, V., Marsboom, G., de Cárcer, G., Acosta‐Iborra, B., Albacete-Albacete, L., Ordóñez, Á., Serrano‐Oviedo, L., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.017 · Cited by 206 · see citing works

Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting

Alkan, H. F., Walter, K. E., Luengo, A., Madreiter‐Sokolowski, C. T., Stryeck, S., Lau, A. N., Zoughbi, W. A., Lewis, C. A., Thomas, C. J., Höefler, G., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.021 · Cited by 205 · see citing works

Specific growth response of ras-transformed embryo fibroblasts to tumour promoters

Dotto, G. P., Parada, L. F., & Weinberg, R. A. (1985) · Nature · doi:10.1038/318472a0 · Cited by 201 · see citing works

Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis

Yue, M., Jiang, J., Gao, P., Liu, H., & Qing, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.002 · Cited by 201 · see citing works

Cancer's sweet tooth

Bui, T., & Thompson, C. B. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.012 · Cited by 195 · see citing works

Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts

Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., & Chiaradonna, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004715 · Cited by 164 · see citing works

l ‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms

Kaira, K., Oriuchi, N., Imai, H., Shimizu, K., Yanagitani, N., Sunaga, N., Hisada, T., Tanaka, S., Ishizuka, T., Kanai, Y., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00969.x · Cited by 155 · see citing works

Molecular Mechanisms of PLD Function in Membrane Traffic

Roth, M. G. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00742.x · Cited by 147 · see citing works

Phospholipase D Couples Survival and Migration Signals in Stress Response of Human Cancer Cells

Yang, Z., Rodrik-Outmezguine, V. S., Toschi, A., Shi, M., Li, H., Shen, Y., & Foster, D. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600660200 · Cited by 136 · see citing works

Functional association between Arf and RalA in active phospholipase D complex

Luo, J.-Q., Liu, X., Frankel, P., Rotunda, T., Ramos, M., Flom, J., Jiang, H., Feig, L. A., Morris, A. J., Kahn, R., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3632 · Cited by 134 · see citing works

Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid

Menon, D., Salloum, D., Bernfeld, E., Sher, E. F., Akselrod, A., Frías, M. A., Sudderth, J., Chen, P.-H., DeBerardinis, R. J., & Foster, D. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772988 · Cited by 124 · see citing works

Protein-mediated assembly of succinate dehydrogenase and its cofactors

Vranken, J. G. V., Na, U., Winge, D. R., & Rutter, J. P. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.990556 · Cited by 122 · see citing works

Activation of phospholipase D1 by direct interaction with ADP‐ribosylation factor 1 and RalA

Kim, J. H., Lee, S. D., Han, J. M., Lee, T. G., Kim, Y. D., Park, J. B., Lambeth, J. D., Suh, P., & Ryu, S. H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00661-9 · Cited by 115 · see citing works

The Amidotransferase Family of Enzymes: Molecular Machines for the Production and Delivery of Ammonia

Raushel, F. M., Thoden, J. B., & Holden, H. M. (1999) · Biochemistry · doi:10.1021/bi990871p · Cited by 113 · see citing works

Arfs at a Glance

Jackson, C. L., & Bouvet, S. (2014) · Journal of Cell Science · doi:10.1242/jcs.144899 · Cited by 113 · see citing works

The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code

Vučetić, M., Cormerais, Y., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00319 · Cited by 113 · see citing works

Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame

Gentry, L. R., Martin, T. D., Reiner, D. J., & Der, C. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.09.004 · Cited by 110 · see citing works

Phospholipase D Mediates Nutrient Input to Mammalian Target of Rapamycin Complex 1 (mTORC1)

Xu, L., Salloum, D., Medlin, P. S., Saqcena, M., Yellen, P., Perrella, B., & Foster, D. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.249631 · Cited by 105 · see citing works

RalA Interacts Directly with the Arf-Responsive, PIP2-Dependent Phospholipase D1

Luo, J.-Q., Liu, X., Hammond, S. M., Colley, W. C., Feig, L. A., Frohman, M. A., Morris, A. J., & Foster, D. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6793 · Cited by 99 · see citing works

Acetate Fuels the Cancer Engine

Lyssiotis, C. A., & Cantley, L. C. (2014) · Cell · doi:10.1016/j.cell.2014.12.009 · Cited by 95 · see citing works

Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer

Babu, E., Bhutia, Y. D., Ramachandran, S., Gnana‐Prakasam, J. P., Prasad, P. D., Thangaraju, M., & Ganapathy, V. (2015) · Biochemical Journal · doi:10.1042/bj20150437 · Cited by 90 · see citing works

Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells

Patel, D., Menon, D., Bernfeld, E., Mroz, V., Kalan, S., Loayza, D., & Foster, D. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710145 · Cited by 86 · see citing works

Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance

Lyssiotis, C. A., Son, J., Cantley, L. C., & Kimmelman, A. C. (2013) · Cell Cycle · doi:10.4161/cc.25307 · Cited by 83 · see citing works

The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy

Bhutia, Y. D., Babu, E., Prasad, P. D., & Ganapathy, V. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.04.004 · Cited by 82 · see citing works

Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer

Toda, K., Nishikawa, G., Iwamoto, M., Itatani, Y., Takahashi, R., Sakai, Y., & Kawada, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081632 · Cited by 77 · see citing works

Amino Acids and mTOR Mediate Distinct Metabolic Checkpoints in Mammalian G1 Cell Cycle

Saqcena, M., Menon, D., Patel, D., Mukhopadhyay, S., Chow, V., & Foster, D. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074157 · Cited by 74 · see citing works

CD98hc (SLC3A2) Loss Protects Against Ras-Driven Tumorigenesis by Modulating Integrin-Mediated Mechanotransduction

Estrach, S., Lee, S.-A., Boulter, E., Pisano, S., Errante, A., Tissot, F. S., Cailleteau, L., Pons, C., Ginsberg, M. H., & Féral, C. C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0579 · Cited by 71 · see citing works

Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways

Chatterjee, A., Mukhopadhyay, S., Tung, K. H.-Y., Patel, D., & Foster, D. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.043 · Cited by 70 · see citing works

Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras

Shi, M., Yang, Z., Garcia, A., Xu, L., & Foster, D. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.09.003 · Cited by 68 · see citing works

Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs

Saqcena, M., Mukhopadhyay, S., Hosny, C., Alhamed, A., Chatterjee, A., & Foster, D. A. (2015) · Oncogene · doi:10.1038/onc.2014.207 · Cited by 67 · see citing works

Defective TGF-β signaling sensitizes human cancer cells to rapamycin

Gadir, N., Jackson, D. N., Lee, E., & Foster, D. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210721 · Cited by 64 · see citing works

Phospholipase D–dependent mTOR complex 1 (mTORC1) activation by glutamine

Bernfeld, E., Menon, D., Vaghela, V., Zerin, I., Faruque, P. R., Frías, M. A., & Foster, D. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004972 · Cited by 57 · see citing works

Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma

Anglin, J., Zavareh, R. B., Sander, P. N., Haldar, D., Mullarky, E., Cantley, L. C., Kimmelman, A. C., Lyssiotis, C. A., & Lairson, L. L. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.04.061 · Cited by 39 · see citing works

Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle

Saqcena, M., Patel, D., Menon, D., Mukhopadhyay, S., & Foster, D. A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1046653 · Cited by 34 · see citing works

A Late G1 Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells

Patel, D., Salloum, D., Saqcena, M., Chatterjee, A., Mroz, V., Ohh, M., & Foster, D. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.757864 · Cited by 27 · see citing works

Glutamine reliance in cell metabolism

Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works

Metabolism of Amino Acids in Cancer

Wei, Z. C., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 439 · see citing works

The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives

Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369 · see citing works

Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches

Navarro, C., Ortega, Á., Santeliz, R., Garrido, B., Chacín, M., Galbán, N., Vera, I., Sanctis, J. B. D., & Bermúdez, V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061303 · Cited by 152 · see citing works

PPAR-γ integrates obesity and adipocyte clock through epigenetic regulation of Bmal1

Wang, S., Lin, Y., Gao, L., Yang, Z., Lin, J., Ren, S., Li, F., Chen, J., Wang, Z., Dong, Z., et al. (2022) · Theranostics · doi:10.7150/thno.69054 · Cited by 117 · see citing works

Polystyrene micro and nano-particles induce metabolic rewiring in normal human colon cells: A risk factor for human health

Bonanomi, M., Salmistraro, N., Porro, D., Pinsino, A., Colangelo, A. M., & Gaglio, D. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.134947 · Cited by 105 · see citing works

PFKP alleviates glucose starvation-induced metabolic stress in lung cancer cells via AMPK-ACC2 dependent fatty acid oxidation

Chen, J., Zou, L., Lu, G. X., Grinchuk, O. V., Fang, L., Ong, D. S. T., Taneja, R., Ong, C. N., & Shen, H. (2022) · Cell Discovery · doi:10.1038/s41421-022-00406-1 · Cited by 104 · see citing works

Targeting KRAS in pancreatic cancer

Stickler, S., RATH, B., & Hamilton, G. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.045356 · Cited by 99 · see citing works

Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets

Nan, D., Yao, W., Huang, L., Liu, R., Chen, X., Xia, W., Sheng, H., Zhang, H., Liang, X., & Lü, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02018-6 · Cited by 95 · see citing works

Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy

Bartolacci, C., Andreani, C., Elgammal, Y., & Scaglioni, P. P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.706650 · Cited by 83 · see citing works

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

Casacuberta‐Serra, S., González-Larreategui, Í., Capitán-Leo, D., & Soucek, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01907-z · Cited by 80 · see citing works

Targeting KRAS: from metabolic regulation to cancer treatment

Shi, Y., Zheng, H., Wang, T., Zhou, S., Zhao, S., Li, M., & Cao, B. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02216-3 · Cited by 75 · see citing works

Regulation of Ferroptosis by Amino Acid Metabolism in Cancer

Yang, J., Dai, X., Xu, H., Tang, Q., & Bi, F. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.64982 · Cited by 69 · see citing works

Cellular metabolism: A key player in cancer ferroptosis

Jiang, X., Peng, Q., Peng, M., Oyang, L., Wang, H., Liu, Q., Xu, X., Wu, N., Tan, S., Yang, W., et al. (2024) · 癌症：英文版 · doi:10.1002/cac2.12519 · Cited by 67 · see citing works

A second Warburg‐like effect in cancer metabolism: The metabolic shift of glutamine‐derived nitrogen

Kodama, M., & Nakayama, K. I. (2020) · BioEssays · doi:10.1002/bies.202000169 · Cited by 65 · see citing works

Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer

Pei, S., Zhang, P., Chen, H., Zhao, S., Dai, Y., Yang, L., Kang, Y.-T., Zheng, M.-J., Xia, Y.-Q., & Xie, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1135297 · Cited by 31 · see citing works

Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1

Kandasamy, P., Zlobec, I., Nydegger, D. T., Pujol‐Giménez, J., Bhardwaj, R., Shirasawa, S., Tsunoda, T., & Hediger, M. A. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12999 · Cited by 60 · see citing works

Resistance looms for KRAS G12C inhibitors and rational tackling strategies

Zhang, J., Zhang, J., Liu, Q., Fan, X., Leung, E. L., Yao, X., & Liu, L. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108050 · Cited by 56 · see citing works

Metabolomics of Breast Cancer: A Review

Subramani, R., Poudel, S., Smith, K. D., Estrada, A., & Lakshmanaswamy, R. (2022) · Metabolites · doi:10.3390/metabo12070643 · Cited by 56 · see citing works

De novo nucleotide biosynthetic pathway and cancer

Chen, J., Yang, S., Li, Y., Xu, Z., Zhang, P., Song, Q., Yao, Y., & Pei, H. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.04.018 · Cited by 55 · see citing works

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer

Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 55 · see citing works

Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC

Xia, M., Li, X., Diao, Y., Du, B., & Li, Y. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100920 · Cited by 48 · see citing works

The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues

Sebestyén, A. R., Dankó, T., Sztankovics, D., Moldvai, D., Raffay, R. E., Cervi, C., Krencz, I., Zsiros, V., Jeney, A., & Petővári, G. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10006-2 · Cited by 46 · see citing works

Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies

Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 47 · see citing works

Functional Amino Acids and Autophagy: Diverse Signal Transduction and Application

Liu, C., Ji, L., Hu, J., Zhao, Y., Johnston, L. J., Zhang, X., & Ma, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111427 · Cited by 41 · see citing works

Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation

Yi, Y., Wang, G., Zhang, W., Yu, S., Fei, J., An, T., Yi, J., Li, F., Huang, T., Yang, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55768-9 · Cited by 40 · see citing works

High Levels of Glutaminase II Pathway Enzymes in Normal and Cancerous Prostate Suggest a Role in ‘Glutamine Addiction’

Dorai, T., Dorai, B., Pinto, J. T., Grasso, M., & Cooper, A. J. L. (2019) · Biomolecules · doi:10.3390/biom10010002 · Cited by 38 · see citing works

Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells

Hara, Y., Minami, Y., Yoshimoto, S., Hayashi, N., Yamasaki, A., Ueda, S., Masuko, K., & Masuko, T. (2019) · Cancer Medicine · doi:10.1002/cam4.2689 · Cited by 36 · see citing works

Reprogramming the tumor microenvironment with biotechnology

Kim, M., Lee, N. K., Wang, C. J., Lim, J., Byun, M. J., Kim, T. P., Park, W., Park, D.-H., Kim, S.-N., & Park, C. G. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00343-4 · Cited by 37 · see citing works

Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells

Spada, M., Piras, C., Diana, G., Leoni, V. P., Frau, D. V., Serreli, G., Simbula, G., Loi, R., Noto, A., Murgia, F., et al. (2023) · Antioxidants · doi:10.3390/antiox12030683 · Cited by 36 · see citing works

Glutamine deprivation induces ferroptosis in pancreatic cancer cells

Xiao, Z., Deng, S., Liu, H., Wang, R., Liu, Y., Dai, Z., Gu, W., Ni, Q., Yu, X., Liu, C., et al. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023029 · Cited by 34 · see citing works

The metabolic importance of the glutaminase II pathway in normal and cancerous cells

Dorai, T., Pinto, J. T., Denton, T. T., Krasnikov, B. F., & Cooper, A. J. L. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.114083 · Cited by 32 · see citing works

Metabolic Reprogramming in Thyroid Cancer

Ju, S. H., Song, M., Lim, J. Y., Kang, Y. E., Yi, H., & Shong, M. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1802 · Cited by 37 · see citing works

Architectural control of metabolic plasticity in epithelial cancer cells

Al‐Masri, M., Paliotti, K., Tran, R., Halaoui, R., Lelarge, V., Chatterjee, S. J., Wang, L., Moraes, C., & McCaffrey, L. M. (2021) · Communications Biology · doi:10.1038/s42003-021-01899-4 · Cited by 31 · see citing works

Metaboloepigenetics in cancer, immunity, and cardiovascular disease

Keating, S. T., & El‐Osta, A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac058 · Cited by 29 · see citing works

Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer

Hanada, K., Kawada, K., Nishikawa, G., Toda, K., Maekawa, H., Nishikawa, Y., Masui, H., Hirata, W., Okamoto, M., Kiyasu, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.023 · Cited by 27 · see citing works

Proline dehydrogenase in cancer: apoptosis, autophagy, nutrient dependency and cancer therapy

Liu, Y., Mao, C., Liu, S., Xiao, D., Shi, Y., & Tao, Y. (2021) · Amino Acids · doi:10.1007/s00726-021-03032-5 · Cited by 25 · see citing works

Glutamic oxaloacetic transaminase 1 as a potential target in human cancer

Song, Z., Yang, Y., Wu, Y., Zheng, M., Sun, D., Li, H., & Chen, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174754 · Cited by 24 · see citing works

Dietary Manipulation of Amino Acids for Cancer Therapy

Jiménez‐Alonso, J. J., & López‐Lázaro, M. (2023) · Nutrients · doi:10.3390/nu15132879 · Cited by 24 · see citing works

Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] Pathway

Cooper, A. J. L., Dorai, T., Pinto, J. T., & Denton, T. T. (2023) · Biology · doi:10.3390/biology12081131 · Cited by 23 · see citing works

Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors

Karagiannis, D., Wu, W., Li, A. M., Hayashi, M., Chen, X., Yip, M., Mangipudy, V. S., Xu, X., Rivera, F. J. S., Soto‐Feliciano, Y. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113629 · Cited by 23 · see citing works

Curcumin and Ferroptosis: a Promising Target for Disease Prevention and Treatment

Foroutan, Z., Butler, A. E., Zengin, G., & Sahebkar, A. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01212-6 · Cited by 23 · see citing works

Complex metabolic interactions between ovary, plasma, urine, and hair in ovarian cancer

Zhong, X., Ran, R., Gao, S., Shi, M., Shi, X., Long, F., Zhou, Y. R., Yang, Y., Tang, X., Lin, A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.916375 · Cited by 22 · see citing works

Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity

Wang, X., Xiao-xia, Y., Peng-Fei, S., Zong-Xue, Z., & Xiu-li, G. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175323 · Cited by 23 · see citing works

Targeting Asparagine Metabolism in Solid Tumors

Hanada, K., Kawada, K., & Obama, K. (2025) · Nutrients · doi:10.3390/nu17010179 · Cited by 20 · see citing works

High glutamine increases stroke risk by inducing the endothelial‐to‐mesenchymal transition in moyamoya disease

He, Q., Li, J., Tao, C., Zeng, C., Liu, C., Zheng, Z., Mou, S., Liu, W., Zhang, B., Yu, X., et al. (2024) · MedComm · doi:10.1002/mco2.525 · Cited by 17 · see citing works

Inhibition of Glutamate‐to‐Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer Cells

Yu, T., der Jeught, K. V., Zhu, H., Zhou, Z., Sharma, S., Liu, S., Eyvani, H., So, K. M., Singh, N., Wang, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202310308 · Cited by 18 · see citing works

Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome

Duan, Y., Zhang, D., Yan, Y., Zheng, S., Huang, P., Zhang, F., Mo, G., Huang, F., Yin, Q., Li, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.765563 · Cited by 18 · see citing works

Correlation between amino acid metabolism and self-renewal of cancer stem cells: Perspectives in cancer therapy

Zhang, Q., & Li, W. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i4.267 · Cited by 15 · see citing works

Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers

Moss, D., McCann, C. K., & Kerr, E. M. (2022) · Science Signaling · doi:10.1126/scisignal.abj3490 · Cited by 15 · see citing works

Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer

Hussein, S., Khanna, P., Yunus, N., & Gatza, M. L. (2021) · Cancers · doi:10.3390/cancers13194808 · Cited by 15 · see citing works

Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer

Li, Y., Hu, L., Peng, X., Xu, H., Tang, B., & Xu, C. S. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.102 · Cited by 13 · see citing works

Ferroptosis and its role in gastric and colorectal cancers

Hou, J., Wang, B., Li, J., & Liu, W. (2024) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2024.28.3.183 · Cited by 13 · see citing works

Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells

Hatipoglu, A., Menon, D., Levy, T., Frías, M. A., & Foster, D. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276579 · Cited by 13 · see citing works

Metabolomic Study on the Therapeutic Effect of the Jianpi Yangzheng Xiaozheng Decoction on Gastric Cancer Treated with Chemotherapy Based on GC-TOFMS Analysis

Hou, C., Chu, H.-J., Dai, X., Wu, Y., He, Z., Yu, Y., Lu, Q., Liu, Y., & Zhang, X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8832996 · Cited by 12 · see citing works

Burgeoning Strategies for Cancer Therapy Based on Ferroptosis Induced by Nanomaterials

Gao, F., Liu, H., Liu, J., & Chen, C. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202511199 · Cited by 11 · see citing works

Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction

Monferrer, E., Vieco-Martí, I., López-Carrasco, A., Fariñas, F., Abanades, S., de la Cruz‐Merino, L., Noguera, R., & Naranjo, T. Á. (2021) · Metabolites · doi:10.3390/metabo11050264 · Cited by 11 · see citing works

Inflammatory Processes: Key Mediators of Oncogenesis and Progression in Pancreatic Ductal Adenocarcinoma (PDAC)

Liu, Y., Qiao, S., Zhang, G., Lü, A., & Li, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010991 · Cited by 10 · see citing works

Glutamine transporter inhibitor enhances the sensitivity of NSCLC to trametinib through GSDME-dependent pyroptosis

Liu, Q., Hu, J., Li, X., Gao, H., Kong, D., & Jin, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116796 · Cited by 10 · see citing works

Glutamine metabolism and ammonia death: targeted modulation for enhanced cancer immunotherapy

Du, F., Xiao, L., Guojun, W., Dai, Q., Li, J., Zhao, X., Zhang, Q., Yang, L., Liu, Y., Hu, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1643017 · Cited by 9 · see citing works

Metabolic reprograming of antioxidant defense: a precision medicine perspective for radiotherapy of lung cancer?

Matschke, J., Larafa, S., & Jendrossek, V. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200866 · Cited by 8 · see citing works

Targeting amino acid in tumor therapy

Ge, M., Xu, Y., Cui, L., Huang, E., Liu, Z., & Yin, K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1582116 · Cited by 8 · see citing works

Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL

Chen, C., Guo, W., Wang, H., Cao, L., & Bai, O. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1659011 · Cited by 6 · see citing works

Multi-omics profiling of intercellular immunometabolic heterogeneity highlights in lung cancer: Crosstalk mechanisms and resistance in the tumor–immune interface

Rukonge, P. A., Kawuribi, V., Sheng, Y., Wei, Q., Kun, Y., Niyodukunda, P., Wang, T., Lu, Z., Miao, Y., Xu, K., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105094 · Cited by 6 · see citing works

Glutamic Acid Modified Gold Nanorod Sensor for the Detection of Calcium ions in Neuronal Cells

Pathiripparambath, M. S. R., Joseph, M., Manog, M., Thomas, V., Tharayil, H., & Nair, L. V. (2024) · ChemBioChem · doi:10.1002/cbic.202400009 · Cited by 5 · see citing works

α-Ketoglutaramate—A key metabolite contributing to glutamine addiction in cancer cells

Cooper, A. J. L., Dorai, T., Pinto, J. T., & Denton, T. T. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1035335 · Cited by 5 · see citing works

Combined inhibition of hexokinase 2 and pyruvate dehydrogenase surmounts SHP2 inhibitor resistance in non-small cell lung cancer with hybrid metabolic state harboring KRAS Q61H mutation

Shan, W., Zhang, S., Assaraf, Y. G., & Tam, K. Y. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167859 · Cited by 4 · see citing works

Systematic and precise interventions for KRAS-mutant cancers

Liang, J., Wu, J., Zhang, Y., Wang, H., Zheng, Y., & He, Q. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00763-7 · Cited by 3 · see citing works

Developing a prognostic model of glutamine metabolism-related genes associated with clinical features and immune status in melanoma

Hu, H., Yang, J., Miao, J., Li, C., Wang, C., Ran, F., Zou, J., Zhang, Y., Zhao, L., Zhao, W., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1485006 · Cited by 3 · see citing works

Glutamine metabolism reprogramming promotes bladder cancer progression via PYCR1: a multi-omics and functional validation study

Ding, X., Zhang, E., Huang, Z., Li, X., Wang, Z., Wu, Y., Liu, C., & Wu, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07386-2 · Cited by 3 · see citing works

Protective effects of glutamine on lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice

Yang, M., Zhang, X., Zhao, S., Shao, R., Fan, K., Hu, K., Zhang, L., & Yang, Y. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221126562 · Cited by 3 · see citing works

TRPML1 signaling at lysosomes-mitochondria nexus drives triple-negative breast cancer mitophagy, metabolic reprogramming and chemoresistancePreprint

Syeda, A. K. R., Almasi, S., Benson, C. J., Kennedy, B. E., Yoast, R. M., Emrich, S. M., Slade, L., Pakkiriswami, S., Vijayan, V. V., Gujar, S. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.11.675705 · Cited by 3 · see citing works

Glutamine synthetase modulates YAP activation by stabilizing LATS under glutamine homeostasis

Li, S., Ling, T., Wang, Y., Shi, J., Wang, Q., Lv, J., Li, J., Liu, Y., Zhang, Y., Liu, C., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116620 · Cited by 2 · see citing works

Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients

Meng, X., Wang, L., He, M., Yang, Z., Jiao, Y., Hu, Y., & Wang, K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269998 · Cited by 2 · see citing works

LINC00114 promotes colorectal cancer metastasis by targeting HNRNPA1 to regulate glutamine metabolism reprogramming and angiogenesis

Tang, S., Liu, M., Zhu, Y., Li, L., Qing, C., Guan, Y., Zhou, T., & Tang, X. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025141 · Cited by 1 · see citing works

Glutamine homeostasis regulates PD-L1 level through STAT3 in pancreatic cancer

Li, Z., Otkur, W., Qi, H., Li, J., Li, S., Ling, T., Wang, H., Li, R., Zhang, Q., Sun, Y., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102092 · Cited by 1 · see citing works

Modifikasi Makanan Enteral Tinggi Asam Amino Essensial

Putriningtyas, N. D., Tyastuti, L. E., & Purwaningsih, S. (2023) · Nutri-Sains Jurnal Gizi Pangan dan Aplikasinya · doi:10.21580/ns.2023.7.1.11759 · Cited by 1 · see citing works

Molecular biomarkers in pancreatic ductal adenocarcinoma

Tsuboi, J., Yamada, R., & HIROKAWA, Y. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95114-2.00016-9 · Cited by 1 · see citing works

Identification of Metabolic Characteristic–Pancreatic Ductal Adenocarcinoma Associations Using Mendelian Randomization and Metabolomics

Xiang, Y., Zhang, C., Wang, J., Cheng, Y., Wang, K., Wang, L., Tong, Y., & Dong, Y. (2025) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-025-01173-4 · Cited by 1 · see citing works

Proline Maintains the Proliferation of Hepatocellular Carcinoma Cells by Decreasing Intracellular Oxidative Stress and Reducing Autophagy During Acute Nutrient StressPreprint

Liu, Z., Li, X., Ge, Q., Yang, F., Sun, S., & Ge, N. (2023) · Research Square · doi:10.21203/rs.3.rs-2777810/v1 · Cited by 1 · see citing works

Supernumerary Centrosome Promotes Glycogen Levels in Hepatocytes Via Metabolic Reprogramming in DEN/CCL4-Induced MicePreprint

Yu, O. L., Zhou, Y., Lim, C. W., & CHING, Y. P. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4635430

Radiotherapy followed by metformin neoadjuvant therapy drives superior pancreatic cancer ferroptosis and augments anti-tumor immunity

Zhu, H., Gong, Y., Wang, X., Zhang, Z., Wang, B., Xu, W., Su, Y., Eriksson, J. E., Wang, D., Wei, S., et al. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.12.010

Overcoming drug resistance in diffuse large b-cell lymphoma by targeting cell metabolism and the alternative NF-kB pathway

Nuan-Aliman, S. (2021) · doi:10.70675/e6d0d159zab42z4fb6zb34fzea69d6185e2a

Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation

Peng, X., Liu, S., & Tao, Y. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00812-1

TRPML1 loss disrupts lysosome–mitochondria homeostasis and sensitizes MDA-MB-231 triple-negative breast cancer cells to chemotherapy

Syeda, A. K. R., Almasi, S., Benson, C. J., Kennedy, B. E., Yoast, R. E., Emrich, S. M., Delima-Baril, A., Slade, L., Pakkiriswami, S., Vijayan, V. V., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113596 · Cited by 3 · see citing works

Glutamine addiction: a new therapeutic target in cancer

Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770 · see citing works

Glutamine metabolism in prostate cancer

Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00001-1

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer

Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 55 · see citing works

Diseases & Disorders | Therapies Targeting Glutamine Addiction in Cancer

Attarwala, N., Zhang, C., & Le, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00079-7 · Cited by 4 · see citing works

Glutamine addiction in tumor cell: oncogene regulation and clinical treatment

Li, X., Peng, X., Li, Y., Wei, S., He, G., Liu, J., Li, X., Yang, S., Dai, L., Lin, W., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01449-x · Cited by 99 · see citing works